Dicer Expression in Estrogen Receptor–positive Versus Triple-Negative Breast Cancer: An Antibody Comparison

Human Pathology - United Kingdom
doi 10.1016/j.humpath.2016.05.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Androgen Receptor-Positive, Triple-Negative Breast Cancer

Cancer
Cancer ResearchOncology
2017English

Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor-Positive Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2011English

Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

Characterization of the Interactions Between Calmodulin and Death Receptor 5 in Triple-Negative and Estrogen Receptor-Positive Breast Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Mesothelin Expression and Survival Outcomes in Triple Receptor Negative Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2013English

TOP2A RNA Expression and Recurrence in Estrogen Receptor-Positive Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment

Oncotarget
Oncology
2018English

Estrogen Independent Gene Expression Defines Clinically Relevant Subgroups of Estrogen Receptor Positive Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

PD-L1 Expression in Triple-Negative Breast Cancer

Cancer immunology research
Cancer ResearchImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy